Jessica Boyd, PhD, FCACB, DABCC (TC)

Associate Professor (Clinical), University of Utah School of Medicine

Specialties

• Urine drug screening
• Therapeutic drug monitoring

Education

• Doctorate Degree—Medical Sciences (Analytical and Environmental Toxicology), University of Alberta
• Fellowship—Clinical Chemistry, University of Calgary/Calgary Laboratory Services

Certification/Affiliations

• Fellow of the Canadian Academy of Clinical Biochemistry
• American Board of Clinical Chemistry (Toxicological Chemistry)
• American Association of Clinical Chemistry
• Canadian Society of Clinical Chemists
• International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Research Interests

• Urine drug screening
• Dried specimen analysis

Awards

• 2018 Canadian Society of Clinical Chemists Award for Innovation in Laboratory Medicine
• 2016 Laboratory Director Grant, Mass Spectrometry Applications in the Clinical Laboratory

Recent Publications

• Wickramarachchi,  Boyd JM, Orton DJ. Biological variation in clozapine and metabolite reporting during therapeutic drug monitoring. Clin Chim Acta. 2022;531:183-187.
• Kline GA, Boyd J, Hyrcza M, et al. Updated reference intervals for urine normetanephrine have no effect on test sensitivity but fewer false positives. Clin Biochem. 2022;99:17-19.
• Kline GA, Boyd J, Sadrzadeh HSM, et al. Inpatient measurements of urine metanephrines are indistinguishable from pheochromocytoma: retrospective cohort study. Am J Med. 2021;134(8):1039-1046.e3.
• Kline GA, Boyd J, Polzin B, et al. Properly collected plasma metanephrines excludes PPGL after false-positive screening tests. J Clin Endocrinol Metab. 2021;106(8):e2900-e2906.
• Qasrawi DO, Boyd JM, Sadrzadeh SMH. Measuring steroids from dried blood spots using tandem mass spectrometry to diagnose congenital adrenal hyperplasia. Clin Chim Acta. 2021;520:202-207.
• Leung AA, Pasieka JL, Hyrcza MD, et al. Epidemiology of pheochromocytoma and paraganglioma: population based cohort study. Eur J Endocrinol. 2021;184(1):19-28. 
• Snozek CLH, Baskin LB, Boyd JM, et al. How can routine clinical laboratories keep up with the opioid crisis? Clin Chem. 2021;67(2):338-344.
• Kline GA, Boyd J, Leung AA, et al. Moderate renal impairment does not preclude the accuracy of 24-hour urine normetanephrine measurements for suspected pheochromocytoma. Clin Endocrinol. 2020;92(6):518-524.
• Kline GA, Boyd J, Leung AA, et al. Very high rate of false positive biochemical results when screening for phaeochromocytoma in a large undifferentiated population with variable indications for testing. Clin Biochem. 2020;77:26-31.
• Boyd J, Boyd J, Leung AA, et al. A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position. Eur J Endocrinol. 2019;181(3): 301-309.
• Saini R, Railton P, Boyd J, et al. Concordance between laboratories in metal ion testing in patients with metal-on-metal hip implants. Can J Surg. 2019;62(1):9-13.
• Boyd J, et al. Limitations of immunoassays for screening of drugs of abuse in urine: issues of false positive and false negative results. In: Dasgupta A, Sepulveda JL, eds. Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction. 2nd ed. St. Louis, MO: Elsevier; 2019:233-242.